Next Article in Journal
Modulation of the Oxidative Stress and Lipid Peroxidation by Endocannabinoids and Their Lipid Analogues
Next Article in Special Issue
The Use of Intravenous Vitamin C as a Supportive Therapy for a Patient with Glioblastoma Multiforme
Previous Article in Journal / Special Issue
High Vitamin C Status Is Associated with Elevated Mood in Male Tertiary Students
Open AccessCase Report

Intravenous Vitamin C Administration Improved Blood Cell Counts and Health-Related Quality of Life of Patient with History of Relapsed Acute Myeloid Leukaemia

1
Integrated Health Options Ltd., Auckland 1050, New Zealand
2
Department of Pathology and Biomedical Science, University of Otago, Christchurch 8011, New Zealand
3
Feedback Research Ltd., Auckland 1050, New Zealand
*
Author to whom correspondence should be addressed.
Antioxidants 2018, 7(7), 92; https://doi.org/10.3390/antiox7070092
Received: 8 June 2018 / Revised: 10 July 2018 / Accepted: 12 July 2018 / Published: 16 July 2018
(This article belongs to the Special Issue Vitamin C: Current Concepts in Human Physiology)
A 52-year-old female presented to Integrated Health Options Clinic in October 2014 with a history of relapsed acute myeloid leukaemia (AML, diagnosed in 2009 and relapsed in 2014). Intravenous(IV) vitamin C therapy was initiated (in 2014) following completion of chemotherapy as an alternative to haematopoietic stem cell transplantation. IV vitamin C was administered twice weekly at a dose of 70 g/infusion. Within 4 weeks of initiation of IV vitamin C therapy, there was a dramatic improvement in the patient’s blood indices with platelet cell counts increasing from 25 × 109/L to 196 × 109/L and white blood cell counts increasing from 0.29 × 109/L to 4.0 × 109/L, with further improvements observed over the next 18 months. Furthermore, there was a clear and sustained improvement in the patient’s health-related quality of life scores assessed using a validated questionnaire. She has remained healthy and in complete remission until the present day. This case study highlights the benefits of IV vitamin C as a supportive therapy for previously relapsed AML. View Full-Text
Keywords: vitamin C; intravenous vitamin C; leukemia; acute myeloid leukemia; AML vitamin C; intravenous vitamin C; leukemia; acute myeloid leukemia; AML
Show Figures

Figure 1

MDPI and ACS Style

Foster, M.N.; Carr, A.C.; Antony, A.; Peng, S.; Fitzpatrick, M.G. Intravenous Vitamin C Administration Improved Blood Cell Counts and Health-Related Quality of Life of Patient with History of Relapsed Acute Myeloid Leukaemia. Antioxidants 2018, 7, 92.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop